Citations are updated once a week. Recently added citations may not appear.
Context | Citation |
---|---|
Limosilactobacillus fermentum (probiotic) |
?
Estimating modifiers from bacteria associations Microbiome Prescription (Lassesen Consulting, LLC ) Vol: 2023 Issue 3 Pages: 3342-3347 Pub: 2023 Apr Epub: Authors K Lassesen , Publication |
Limosilactobacillus fermentum (probiotic) |
?
Probiotic properties of vaginal lactic acid bacteria to prevent metritis in cattle. Letters in applied microbiology (Lett Appl Microbiol ) Vol: 43 Issue 1 Pages: 91-7 Pub: 2006 Jul Epub: Authors Otero MC , Morelli L , Nader-Macías ME , Publication |
Limosilactobacillus fermentum (probiotic) |
?
Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections. International journal of antimicrobial agents (Int J Antimicrob Agents ) Vol: 42 Issue 6 Pages: 475-81 Pub: 2013 Dec Epub: 2013 Sep 7 Authors Sikorska H , Smoragiewicz W , Publication |
Limosilactobacillus fermentum (probiotic) |
?
A synbiotic composed of Lactobacillus fermentum CECT5716 and FOS prevents the development of fatty acid liver and glycemic alterations in rats fed a high fructose diet associated with changes in the microbiota. Molecular nutrition & food research (Mol Nutr Food Res ) Vol: 61 Issue 8 Pages: Pub: 2017 Aug Epub: 2017 Jun 8 Authors Rivero-Gutiérrez B , Gámez-Belmonte R , Suárez MD , Lavín JL , Aransay AM , Olivares M , Martínez-Augustin O , Sánchez de Medina F , Zarzuelo A , Publication |
Limosilactobacillus fermentum (probiotic) |
?
Lactobacillus fermentum FTDC 8312 combats hypercholesterolemia via alteration of gut microbiota. Journal of biotechnology (J Biotechnol ) Vol: 262 Issue Pages: 75-83 Pub: 2017 Nov 20 Epub: 2017 Sep 19 Authors Lye HS , Kato T , Low WY , Taylor TD , Prakash T , Lew LC , Ohno H , Liong MT , Publication |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.